| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Viridian Therapeutics, Inc.\de (VRDN) has 8 insiders with recent SEC Form 4 filings, including 7 buys and 9 sells. VRDN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.91M | $65.47M | - | |
| Dir | 21.0K | $351.2K | - | |
| Dir | 21.0K | $351.2K | - | |
| Dir | 21.0K | $351.2K | - | |
| Dir | 21.0K | $351.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2022 | Violin Jonathan47 | Chief Executive Officer | Sell | 30,000 | $12.20 | $366,000.00 | -5.9% | +78.7% | +101.8% | |
| May 2, 2022 | Violin Jonathan47 | Chief Executive Officer | Sell | 30,000 | $13.04 | $391,200.00 | -5.5% | +5.1% | +115.9% | |
| Apr 4, 2022 | Violin Jonathan47 | Chief Executive Officer | Sell | 30,000 | $18.92 | $567,636.00 | -2.7% | -40.6% | +33.6% | |
| Mar 2, 2022 | Violin Jonathan47 | Chief Executive Officer | Sell | 30,000 | $17.65 | $529,491.24 | -2.5% | -29.7% | +87.5% | |
| Feb 3, 2022 | Violin Jonathan47 | Chief Executive Officer | Sell | 30,000 | $19.09 | $572,818.29 | -1.6% | -38.5% | +90.6% | |
| Sep 23, 2021 | Frazier Life Sciences Public Fund, L.P. | 10% Owner | Buy | 200,000 | $11.00 | $2,200,000.00 | +15.3% | +45.2% | +43.8% | |
| Sep 21, 2021 | Fairmount Funds Management LLC73 | Director, 10% Owner | Buy | 909,000 | $11.00 | $9,999,000.00 | +3,109% | +57.8% | +64.5% | |
| Nov 13, 2020 | Logos Global Master Fund LP | 10% Owner | Buy | 476,667 | $4.76 | $2,270,483.95 | +3.8% | - | - | |
| Oct 11, 2018 | Hughes Thomas E. | Director | Buy | 10,000 | $4.77 | $47,697.00 | +353.7% | - | - | |
| Feb 13, 2018 | Booth Bruce70 | Director | Buy | 545,454 | $5.50 | $2,999,997.00 | +67.7% | - | - |